(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,
11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,
12-dione (Molecular Formula: C₂₇H₂₉NO₁₁)

Product Name:	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9, 11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5, 12-dione
CAS Registry Number:	23214-92-8
EINECS:	245-495-6
Synonyms:	Adriamycin; Adriablastin; Doxil; Doxorubicinum; Adriblastin; Doxorubicine; Adriblastina; Myocet;(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9, 11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5, 12-dione; Rubex;
Molecular Structure:
Molecular Formula:	C₂₇H₂₉NO₁₁
Molecular Weight:	543.51926
Density:	1.61 g/cm³
Boiling Point:	RELATIVE DENSITY
Melting Point:	205℃
Flash Point:	443.8 °C
Refractive index:	1.709
Safety Statements:	Confirmed carcinogen with experimental carcinogenic, neoplastigenic, and tumorigenic data. Poison by intraperitoneal, subcutaneous, parenteral, and intravenous routes. Human systemic effects by intravenous route: cardiac myopathy including infarction, nausea or vomiting, and effects on the hair. An experimental teratogen. Other experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits very toxic fumes of NOx and HCl.
Hazard Symbols:	UN NO.

(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione (Molecular Formula: C27H29NO11)